Pfizer Inc.

NYSE:PFE  
41.49
-0.18 (-0.43%)
5:05:38 PM EDT: $41.51 +0.02 (+0.05%)
Products, Community

FDA Vaccine Advisers To Vote on If Data Support Approval Of Booster Shot Of Pfizer's COVID-19 Vaccine

Published: 09/17/2021 13:33 GMT
Pfizer Inc. (PFE) - FDA Vaccine Advisers to Vote on Whether Safety and Effectiveness Data Support Approval of Third Shot of Pfizer's Covid-19 Vaccine at Least 6 Months After Full Vaccination in People 16 and Older.
Cdc Says It is Difficult to Distinguish Between the Effect of Time and the Rise of the Delta Variant on Waning Immunity After Full Vaccination - Presentation.
Reuters Story : Id:nl1n2qj0ov.
Link for the FDA Advisory Committee: (https://bit.
Ly/3eup8cy).
Further Company Coverage: Pfen ((reuters.
Briefs@thomsonreuters.
Com;)).